March 16, 2017
Adapt Pharma (www.AdaptPharma.com) today presented results of a survey conducted with Police and Community Organizations describing real-world experiences and outcomes with the FDA-approved 4mg...
February 28, 2017
NARCAN® Nasal Spray is the only FDA-approved naloxone nasal spray indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous syste...
February 21, 2017
Adapt Pharma Limited (Adapt Pharma) today announced that a marketing application for Naloxone Hydrochloride (HCl) Nasal Spray for the treatment of opioid overdose has been filed in Europe....